uploads///Chart

Pfizer’s Quarterly Revenue Trend in Q2 2018

By

Dec. 4 2020, Updated 10:53 a.m. ET

Pfizer’s revenue

Pfizer (PFE) reports its revenue into two business segments: Innovative Health and Essential Health.

As we discussed in the previous article, Pfizer reported a YoY (year-over-year) rise of 4% in its top line to $13.5 billion in the second quarter compared to $12.9 million during the second quarter of 2017. This outperformance was driven by a 2% favorable foreign exchange impact and a 2% rise in operating revenue in the second quarter.

The chart above shows Pfizer’s revenues since the first quarter of 2017.

Article continues below advertisement

Business segments

The Innovative Health segment reported revenue of $8.27 billion in the second quarter, an 8% rise YoY compared to $7.67 billion during the second quarter of 2017. This rise included a 5% rise in operating revenue and a 3% favorable impact of foreign exchange.

The Essential Health segment reported revenue of $5.19 billion in the second quarter, a 1% fall YoY compared to $5.23 billion during the second quarter of 2017. This fall included a 4% fall in operating revenue offset by a 3% favorable impact of foreign exchange.

Revenue by geography

The US markets reported a 2% fall in revenue to $6.3 billion in the second quarter compared to ~$6.3 billion in the second quarter of 2017. The fall was driven by a 14% fall in the sales of the company’s Essential Health products to ~$1.6 billion in the quarter, and it was partially offset by a 3% rise in the sales of Innovative Health products to ~$4.6 billion.

The international markets reported an 11% rise in revenue to ~$7.2 billion in the second quarter, including a 5% operational rise and a 6% favorable impact of foreign exchange.

The iShares US Healthcare ETF (IYH) holds 6.4% of its total investments in Pfizer, 9.6% in Johnson & Johnson (JNJ), 2.7% in Gilead Sciences (GILD), and 4.8% in Merck & Co. (MRK).

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.